Emil Pharmaceutical Industries Pvt Ltd Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Emil Pharmaceutical Industries Pvt Ltd Pharmaceutical Export Portfolio Dataset — 3 Products, $8.7M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Emil Pharmaceutical Industries Pvt Ltd — Pharmaceutical Exporter Profile (2026) | 3 Products, $8.7M Trade | TransData Nexus

Emil Pharmaceutical Industries Pvt Ltd

Indian Pharmaceutical Exporter · Cardiovascular Specialist · $8.7M Total Trade · DGFT Verified

Emil Pharmaceutical Industries Pvt Ltd is an Indian pharmaceutical exporter with a total trade value of $8.7M across 3 products in 2 therapeutic categories. Based on 212 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Losartan ($5.7M), Sertraline ($1.8M), Enalapril ($1.2M).

Emil Pharmaceutical Industries Pvt Ltd — Export Portfolio & Destination Treemap

Emil Pharmaceutical Industries Pvt Ltd pharmaceutical export portfolio — 3 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Emil Pharmaceutical Industries Pvt Ltd? — Company Overview & Market Position

Emil Pharmaceutical Industries Pvt. Ltd., established in 1989, is a privately held pharmaceutical company headquartered in Mumbai, Maharashtra, India. The company is registered under the Corporate Identification Number (CIN) U24230MH1986PTC039809. As of the latest available data, Emil Pharmaceutical Industries has an authorized capital of ₹1000.0 lakhs and a paid-up capital of ₹764.56 lakhs, reflecting a paid-up capital percentage of 76.45614%.

The company operates in the manufacturing sector, specifically focusing on pharmaceuticals, medicinal chemicals, and botanical products. Emil Pharmaceutical Industries has a workforce of approximately 201 to 500 employees, indicating a substantial operational scale. Their product portfolio includes tablets, capsules, syrups, and injections, catering to various therapeutic categories. The company's official website is www.emilpharma.in, providing comprehensive information about their products and services.

What Does Emil Pharmaceutical Industries Pvt Ltd Export? — Product Portfolio Analysis

Top Products by Export Value

1Losartan$5.7M 2

Product Portfolio — Top 3 by Export Value

Emil Pharmaceutical Industries Pvt Ltd exports 3 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Losartan	Cardiovascular	$5.7M	113	1.9%	8
2	Sertraline	CNS & Psychiatric	$1.8M	53	0.3%	15
3	Enalapril	Cardiovascular	$1.2M	46	0.5%	9

Emil Pharmaceutical Industries Pvt Ltd exports 3 pharmaceutical products across 2 therapeutic categories with a total export value of $8.7M. The top category is Cardiovascular (79.0% of portfolio), followed by CNS & Psychiatric (21.0%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Emil Pharmaceutical Industries Pvt Ltd — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Emil Pharmaceutical Industries Pvt. Ltd. operates multiple manufacturing units, including a new greenfield facility, to enhance its production capabilities. The company has two existing units with a combined volume of approximately 3.3 billion tablets, 1.8 billion capsules, and 42 million dry powder packs. Unit 1 is accredited with Good Manufacturing Practice (GMP) certification, while Unit 2 holds certifications from the World Health Organization (WHO) GMP, FDA Philippines, NMRA Sri Lanka, NAFDAC Nigeria, FDA Ghana, Ministry of Health (MOH) UAE, and PPB Kenya. The new greenfield manufacturing facility is expected to double the company's manufacturing capabilities by 2025.

3Key Leadership

The leadership team at Emil Pharmaceutical Industries Pvt. Ltd. comprises experienced professionals dedicated to steering the company towards growth and innovation. Key executives include:

Tushar Anil Korday: Co-founder and Director, serving since May 13, 1986.
Rajendra Fattesinh Gole: Co-founder and Technical Director, serving since May 13, 1986.
Sumegha Sanjiv Patange: Director, serving since February 24, 2004.
Manjiri Anil Devdhar: Director, serving since February 24, 2004.

These leaders bring a wealth of experience and strategic vision to the company, contributing to its sustained success in the pharmaceutical industry.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Emil Pharmaceutical Industries Pvt Ltd Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Emil Pharmaceutical Industries Pvt. Ltd. has established a significant presence in several regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has made substantial progress in obtaining regulatory approvals and market access in these regions. For instance, Emil has been advancing towards EU Good Manufacturing Practice (GMP) and US FDA approvals to expand its market reach and product portfolio.

In the United States, the company has been actively pursuing facility registrations and approvals for its Abbreviated New Drug Applications (ANDAs) and Drug Master Files (DMFs). While specific details regarding FDA facility registrations and inspection history are not publicly disclosed, Emil's commitment to meeting international standards suggests a proactive approach to compliance.

In the European Union, Emil Pharmaceutical Industries has been working towards obtaining EU GMP certifications, which are essential for market access. The company's efforts to modernize existing units and build new manufacturing facilities indicate a strategic focus on meeting the stringent requirements of the EU market.

2Emerging Markets

Emil Pharmaceutical Industries Pvt. Ltd. has made significant inroads into emerging markets across Africa, Latin America, and Southeast Asia. The company's products are registered in over 25 countries, including regions such as Central and South America, Africa, and Southeast Asia. This extensive registration underscores Emil's commitment to expanding its global footprint and providing affordable healthcare solutions worldwide.

Emil Pharmaceutical Industries Pvt Ltd — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Emil Pharmaceutical Industries Pvt. Ltd. has been actively pursuing compliance with the U.S. Food and Drug Administration (FDA) regulations to enhance its market presence in the United States. The company has been advancing towards obtaining FDA approvals for its manufacturing facilities and products. While specific details regarding FDA facility registrations, approved ANDAs, DMF filings, and inspection history are not publicly disclosed, Emil's commitment to meeting international standards suggests a proactive approach to compliance.

2WHO & EU GMP

Emil Pharmaceutical Industries Pvt. Ltd. has been working towards obtaining EU GMP certifications, which are essential for market access in the European Union. The company's efforts to modernize existing units and build new manufacturing facilities indicate a strategic focus on meeting the stringent requirements of the EU market.

3CDSCO & Indian Regulatory

Emil Pharmaceutical Industries Pvt. Ltd. operates under the regulatory framework of the Central Drugs Standard Control Organisation (CDSCO) in India. The company holds manufacturing licenses from CDSCO, ensuring compliance with national standards for pharmaceutical manufacturing. Additionally, Emil has obtained approvals from various state drug controllers and export No Objection Certificates (NOCs), facilitating its export operations. The company's commitment to adhering to Indian regulatory requirements underscores its dedication to quality and compliance.

Emil Pharmaceutical Industries Pvt Ltd — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Emil Pharmaceutical Industries Pvt. Ltd. operates in a competitive landscape, facing competition from both domestic and international pharmaceutical manufacturers. Key competitors include established Indian pharmaceutical companies and multinational corporations with a presence in the same therapeutic categories. Emil's focus on quality, affordability, and regulatory compliance positions it favorably in the market. The company's strategic partnerships with multinational firms such as Pfizer, Merck, and GSK further enhance its competitive standing.

2Key Differentiators

Emil Pharmaceutical Industries Pvt. Ltd. differentiates itself through several key strengths:

Patient-Centric Approach: Emil prioritizes the well-being of patients, ensuring that its products meet high-quality standards and are accessible.
Cost Competitiveness: The company offers affordable healthcare solutions without compromising on quality.
Timely Deliveries: Emil emphasizes efficient supply chain management to ensure prompt delivery of products.

Frequently Asked Questions — Emil Pharmaceutical Industries Pvt Ltd

How many pharmaceutical products does Emil Pharmaceutical Industries Pvt Ltd export from India?

Emil Pharmaceutical Industries Pvt Ltd exports 3 pharmaceutical products across 2 therapeutic categories. The top exports are Losartan ($5.7M), Sertraline ($1.8M), Enalapril ($1.2M). Total export value is $8.7M.

What is Emil Pharmaceutical Industries Pvt Ltd's total pharmaceutical export value?

Emil Pharmaceutical Industries Pvt Ltd's total pharmaceutical export value is $8.7M, based on 212 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Emil Pharmaceutical Industries Pvt Ltd cover?

Emil Pharmaceutical Industries Pvt Ltd exports across 2 therapeutic categories. The largest are Cardiovascular (79.0%, 2 products), CNS & Psychiatric (21.0%, 1 products).

Get Full Emil Pharmaceutical Industries Pvt Ltd Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.